performed. In the remaining 11 subjects with live fetuses, amniotic fluid studies were performed to determine gestational age which was unknown. The results of these studies äs well äs the examination of the neonate indicated that the pregnancies were at term. In all cases, transabdominal amniocentesis was per· formed andacatheter was placed into the amniotic cavity. Also, a maternal vein of the arm was catheterized. The 13 pregnant women received a single i/v injection of PAH at a rate of 8 mg/Kg, followed by an intravenous infusion of the same substance. In 11 mothers the infusion rate was 380 mcg/min/Kg for 30 minutes, in one mother 240 mcg/min/Kg for 160 minutes and in the remaining subject it was 50 mcg/min/Kg for 450 minutes. Samples of maternal venous blood and amniotic fluid were simultaneously obtained, immediately before PAH administration and every 30 minutes thereafter. PAH concenträtion was measured in each sample using a microtechnique developed at our laboratory which is a modification of that described by HAMBURGER [6] .
Results
Figure l show the results obtained in a mother with live fetus who received the infusion at the lowest rate (50 mcg/min/Kg) during 450 minutes. In maternal plasma, after an initial rise, PAH concenträtion remains almost steady, up to the end of the infusion. In amniotic fluid, there is a continuous rise of PAH concentration from the beginning until the end of the infusion. At 5 hours, PAH concentration becomes equal to that of maternal palsma and from there on the values observed in amniotic fluid were higher. At the end of infusion (07:30 hours) PAH concentration in amniotic fluid was 50% higher than in maternal plasma. After the end of infusion the concentration in maternal plasma feil rapidly whereas in amniotic fluid it showed a very small and slow decline. Three hours after the end of the infusion, concentration in amniotic fluid was still higher than that found in blood during the infusion. Figure 2 shows another study performed in a subject with live fetüs receiving the infusion at a rate of 240 mcg/min/Kg during 160 minutes. Samples öf amniotic fluid were obtained more frequently than in the previous study, pärticülarly during the first 30 minutes. Already at the second minute after the beginning of PAH administration, this substance is detected in amniotic fluid at a concentration of 0,3 mcg/ml. The increment of PAH concentration in amniotic fluid continued during the infusion and even for two hours after its Interruption, although concentrations in maternal plasma feil very rapidly. In this subject, the concentration of the substance in ärpniotic fluid did not attain the concentration in maternal plasma probably because the duration of the infusion is not long enough. Two hours after the end of drug administration, PAH in amniotic fluid began to decrease very slowly (from 11 tö 6 mcg/ml in 5 hours). PAH concentrations in amniotic fluid of nine pregnant women who received infusions at a rate of 380 mcg/min/Kg during 30 minutes are shown in Tab. L PAH increased in all subjects and this increment continued for two or more hours after the Interruption of the infusion. For the same 9 women Figure 3 shows that the mean PAH concentration in amniotic fluid increases äs a linear function of time (r = 0.66, p < 0.001). The mean slope was 5.18 mcg per ml and per hour (± 0.9 SE).
I.V. INFUSION OF PAH
When the fetus was dead a completely different pattern was observed (Fig. 4) . While in live fetuses (Fig. 4,left) the PAH concentration increased until at least two hours after the infusion ceased, in dead fetuses (Fig. 4 , right) the highest concentration was observed in the first sample at the end of the infusion and began to decrease rapidly following a curve parallel to that of maternal plasma one hour after the Interruption of the infusion (Fig. 4 , compare left and right parts).
Discussion
From our results it can be concluded that when PAH is administered to the mother: a) it appears rapidly in amniotic fluid; b) increases during the
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Infusion and continues to increase for two hours after its Interruption although PAH concentration in maternal plasma falls to very low limits. c) PAH disappears from amniotic fluid very slowly. d) Concentration in amniqtic fluid may increase above that in maternal plasma if the infusion is prolonged for a sufficient time. Para-aminohippurate is cleared from blood by the kidney. In human adults 99 per cent of the PAH that enters the organ is eliminated to the urine but only 60 per cent of it is excreted by the normal neonatal kidney (11). The progressive rise of amniotic PAH concentration may be explained äs follows (Fig. 5) . PAH diffuses from maternal to fetal blood through the placenta. The fetal kidney removes PAH from fetal blood and concentrates it in urine. Periodic fetal micturition [5] causes the rise of PAH concentration in amniotic fluid. This is in agreement with the idea that the fetal kidney plays a major role in the cömposition of amniotic fluid during the last trimester of pregnancy. Also, PAH may return from amniotic fluid to fetal blood mainly because of fetal swallowing, and again excreted into this compartment through the urine after being concentrated by the kidney. It must be postulated that the fetal kidney is much more efficient than the placenta in removing PAH from fetal blood. Consequently, this mechanism maintains a recirculation of this substance between amniotic fluid and the fetus ( This would explain the lack of correlation between the concentrations in matemal plasma and in amniotic fluid after the infusion was interrupted äs well äs the slow disappearance of PAH from amniotic fluid. Diffusion of PAH between maternal and fetal blood on one side and amniotic fluid on the other, through the walls of the vessels in the ovular membranes and the umbilical cord, may also exist äs it is accepted for other substances [3, 10] . This mechanism would not play a major role in the concentration of PAH in amniotic fluid, in subjects with live fetuses. When the fetus is dead, none of the above mechanisms is working except diffusion from maternal blood into amniotic fluid and viceversa which is probably enhanced by an alteration in the oyular membranes due to fetal death. Our results also show that mean PAH concentration in amniotic fluid increases äs a linear function of time until 150 minutes after the onset of the infusion.
Assuming that within these limits, the slope of each individual curve is an estimation of the fetal ability to concentrate PAH in amniotic fluid, a clinical test may be designed selecting two samples with one hour interval (i.e. 60 and 120 minutes). The difference of PAH concentrations between samples corresponds to the hourly increment in that concentration and may be employed äs an estimator of fetal health.
Summary
There are few studies in which substances mainly cleared by the kidney are injected tc the mother and the time course of their concentrations in amniotic fluid is analyzed. This type of studies may contribute to the knowledge of the transference of substances through the mother-fetusamniotic fluid complex. Thirteen pregnant women were studied. Eleven with normal term pregnancies, and the remaining two mothers were at the 36th week of gestation and their fetuses were dead. A Saturation dose of para-amino-hippurate (PAH) (8 mg/kg) was administered intravenously to all subjects. This dose was followed by a continuous infusion at a rate of 380 mcg/min/kg during 30 minutes in 11 mothers. In one of the remaining subjects, the infusion rate was 240 mcg/ min/kg during 160 minutes and in the other, it was 50 mcg/min/kg for 450 minutes. Samples of maternal blood and amniotic fluid were simultaneously obtained, before PAH administration and at variable intervals thereafter. In mothers with live fetuses, PAH concentration in amniotic fluid increased not only during the infusion but also for at least two hours after its Interruption (Fig. 2 , Tab. I). When the infusion lasted enough and with stabilized PAH concentration in maternal plasma, amniotic fluid concentration of PAH attained higher values than in the mother (Fig. 1) . Disappearance of PAH from amniotic fluid was very slow (45% in 5 hours) (Fig. 2) . In cases with dead fetuses, the pattern of PAH concentration in amniotic fluid was completely different. The highest concentration was observed already in the first sample at the end of the infusion. From there on, no increment was recorded, and äs soon äs maternal blood concentration feU below the values of amniotic fluid, PAH began to disappear from this compartment at a much faster rate (45% in l hour) (Fig. 3) . The progressive rise of PAH in amniotic fluid may be explained äs follows: (Fig. 5 ). PAH diffuses from maternal blood to fetal blood through the placenta. The fetal kidney removes PAH from fetal blood and concentrates it in urine. Periodic fetal micturition causes the rise of PAH in amniotic fluid. PAH may return from amniotic fluid to fetal blood mainly because of fetal swallowing; and the larger part of this PAH will be again excreted by the kidney into the amniotic compartment. This mechanism would explain the slow disappearance of the substance from amniotic fluid after the end of the infusion, and also the lack of correlation between concentrations in maternal plasma and amniotic fluid. Diffusion of PAH between blood and amniotic fluid may also exist through the walls of the vessels of the ovular membranes and the vessels of the umbilical cord; this mechanism would play a minor roJe in the concentration of PAH in amniotic fluid in subjects with live fetuses. Our results also show that mean PAH concentration in amniotic fluid increases äs a linear function of time until 150 minutes after the onset of PAH administration to the mother (Fig. 4) (Fig. 2) (Tab. I). Lorsque Pinfusion avait dure suffisammcnt et que la concentration de PAH s'etait stabilisee dans le plasma maternel, on observa que la concentration de PAH dans le liquide amniotique atteignait des valeurs plus elevees que chez la mere (Fig. 1) . La disparition de PAH du liquide amniotique a augmente non seulement durant l'infusion, mais aussi pendant deux heures au moins apres son interruption (Fig. 2) (Tab. I). Lorsque l'infusion avait dure suffisamment et que la concentration de PAH s'etait stabilisee dans le plasma maternel, on observa que la concentration de PAH dans le liquide amniotique atteignait des valeurs plus elevees que chez la mere (Fig. 1 ). La disparition de PAH du liquide amniotique ne se fit que tres lentement (45% en 5 heures) (Fig. 2) . Dans les cas des foetus morts, la structure de la concentration de PAH dans le liquide amniotique fut totalement differente. La concentration la plus elevee etait observee des le premier echantillon a la fin de l'infusion. A partir de la, on n'enregistra aucun increment et des que la concentration dans le sang maternel tomba au-dessous des valeurs du liquide amniotique, le PAH commenqa a en disparaitre a un taux beaucoup plus rapide (45% en l heure) (Fig. 3) . La hausse progressive du PAH dans le liquide amniotique peut etre expliquee comme suit: (fig. 5 ). Le PAH se diffuse du sang maternel dans le sang foetal a travers le placenta. Le rein foetal retire le PAH du sang foetal pour le concentrer dans l'urine. La miction foetale periodique provoque la hausse de PAH dans le liquide amniotique. Le PAH peut retourner du liquide amniotique au sang foetal principalement du fait que le foetus avale, et la plus grande part de ce PAH sera a nouveau eliminee par le rein dans le «secteur» amniotique. Ce mecanisme expliquerait la lente disparition de la substance de liquide amniotique apres la fin de Finfusion ainsi que le manque de correlation entre les concentrations dans le plasma maternel et le liquide amniotique. La diffusion de PAH entre le sang et le liquide amniotique peut aussi exister a travers les parois des vaisseaux des membranes ovulaires et des vaisseaux du cordon ombilical; ce mecanisme jouerait un röle moindre dans la concentration de PAH dans le liquide amniotique chez les sujets avec foetus vivants. Nos resultats montrent aussi qu'une concentration moyenne de PAH dans le liquide amniotique augmente comme une fonction lineaire de temps jusqu'a 150 minutes apres le debut de radministration de PAH a la mere (Fig. 4) . Presumant que la «courbe» de chaque individu est une estimation de la capacite foetale a concentrer le PAH dans le liquide amniotique, un test clinique peut etre assigne pour selectionner deux echantillons peut etre utilisee comme facteur d'estimation de la sante du foetus.
Mots-cles: Foetus, grossesse, liquide amniotique, sante foetale, transfert foeto-maternel.
